Latest Piperidines Stories
DUBLIN, May 22, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that a panel of the U.S.
The Firm is representing Risperdal lawsuit plaintiffs who allegedly experienced gynecomastia, or male breast growth, due to their use of the antipsychotic medication. New
93% of patients treated with INVEGA TRINZA(TM) remained relapse-free at the end of long-term maintenance trial TITUSVILLE, N.J., May 19, 2015 /PRNewswire/ -- There's a new treatment option
- NAMZARIC is now available across the United States - DUBLIN, Ireland, May 18, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that NAMZARIC(TM) (memantine hydrochloride extended-release
The founder of Best Drug Rehabilitation, Per Wickstrom, gives information on the deadly drug Acetyl Fentanyl and the new dangers that it poses. Manistee, Michigan
TITUSVILLE, N.J., May 11, 2015 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. announced today that the U.S.
Braeburn acquires six-month risperidone implant from Endo Pharmaceuticals; Phase 3 clinical trial planned for 2015 PRINCETON, N.J., May 1, 2015 /PRNewswire/ -- Braeburn Pharmaceuticals
FDA Approves Labeling Supplement WINNIPEG, April 23, 2015 /PRNewswire/ - Medicure Inc.
Trial is the first to study schizophrenia treatment within the context of many real-world issues faced by patients with schizophrenia TITUSVILLE, N.J., April 15, 2015 /PRNewswire/ -- A study
Clinical Data from Two Different Development Programs Highlight Efficacy and Tolerability of Sublingual Sufentanil in Out-patient and In-patient Surgical Populations REDWOOD CITY,
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.